AGS-003-BLD
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AGS-003-BLD, covering 2017-11-17 to 2017-11-17. Get the full timeline:
Most recent: Clinical Trial Update: Gemcitabine Hydrochloride, Cisplatin, and AGS-003-BLD in Treating Patients With Muscle-Invasive Bladder Cancer Undergoing Surgery [NA]